Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The nuclear cardiology market is focused mainly on three major segments namely, radiology devices, picture archiving and communications systems (PACS) and radiology information systems (RIS) and radiopharmaceuticals. Gamma cameras and positron emission tomography scanners are major imaging devices used in cardiac procedures. SPECT imaging has been the mainstream modality for nuclear cardiology procedures performed worldwide. Radiopharmaceuticals such as nitrogen-13, rubidium-82, fluorine-18, oxygen-15 and other radioisotopes are used in the nuclear imaging process. PACS is an emerging and promising technology in nuclear imaging sector with its potential benefits over other imaging technologies.
For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/5486
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
Aging population and rising cardiovascular incidences are the major driving factors for the nuclear cardiology market. Besides, the demand for graying equipment in the established diagnostic facilities will provide with demand for new equipment with improve patient outcomes and reduced radiation exposure. In addition, new cost effective technologies such as PET and PACS imaging equipment will lead to growth in the demand for nuclear cardiology devices.
To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/5486
Some of the major players in this market include:
- 3mensio Medical Imaging BV
- Bracco Diagnostics
- GE Healthcare
- Shimadzu Corporation
- Siemens Healthcare
- Astellas Pharma US
- Philips Healthcare
- Covidien plc
- Positron Corporation
- Fujifilm Medical Systems USA
- UltraSPECT
About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com